Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 174.85 Bil Enterprise Value: 226.24 Bil PE Ratio: 41.65 PB Ratio: 23.23 GF Score: 91/100

Q4 2020 Amgen Inc Earnings Call Transcript

Feb 02, 2021 / 10:00PM GMT
Release Date Price: $240.98 (-1.17%)
Operator

My name is Erica, and I will be your conference facilitator today for Amgen's Fourth Quarter 2020 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thank you, Erica. Good afternoon, everybody. Welcome to our call to review our Q4 and full year financial results for 2020. I would say the strong execution despite the pandemic and pipeline advancement are 2 themes that were pervasive, so let's get after it. We'll stick to an efficient format of limited prepared comments, our 1 question rule, as Erica pointed out, and the overall duration of the call to 1 hour.

Slides have been posted. Just a quick reminder that we'll use non-GAAP financial measures in our presentation, and some of the statements will be forward-looking. Our SEC filings identify factors that could cause our actual results to differ materially.

So with that, I would like to turn the call over to our Chairman and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot